SwishX has announced its launch, introducing the world’s first agentic Artificial Intelligence (AI) platform built exclusively for pharmaceutical and medtech companies, aimed at transforming sales, marketing, distribution, and business growth through AI.

The Bengaluru-headquartered startup is targeting USD 5 million in contracted ARR and 100+ enterprise customers by end of current FY 2026-27, and plans expansion into Latin America, Southeast Asia, the Middle East, Africa, and Eastern Europe. SwishX has also raised USD 2.2 million in seed funding backed by Powerhouse Ventures, Blume Ventures, Sadev Ventures, Atrium Ventures, and other investors. These emerging markets, along with India, represent a USD 400 billion pharma and medtech opportunity, with commercial operations expected to grow to USD 770 billion by 2033 at a CAGR exceeding 12 percent.

India, dubbed as the 'pharmacy of the world', alone supplies 20 percent of the world’s medicines, and exports to over 200 countries, and is home to the highest number of US Food and Drug (FDA)-approved manufacturing plants outside the US. However, most companies still lack real-time visibility into key business questions–which 300 public sector tenders out of 3,000 they have a real shot at winning, which hospital rate contracts are creating 25 percent+ revenue leakage, what is actually selling at the retailer level, whether marketing efforts to engage doctors is generating results?

All this is part of a long-standing problem in the pharma industry, where many critical commercial decisions still depend on spreadsheets, disconnected software, manual workflows, and delayed reporting. SwishX aims to address these gaps through AI agent-led solutions for core commercial functions (sales, marketing, and distribution) and improve revenue outcomes by up to 30 percent.

SwishX is organised around 4 hubs, each having its own specialised AI agents: Tender IQ (tender and RFP automation), contract IQ (Hospital Rate Contract Automation), marketing IQ (HCP and rep engagement), channel IQ (channel partner engagement). The AI agents capture siloed data, automate business workflows, learn nuances of every decision and build a functional memory to help business teams accelerate their commercial execution.

While starting with India, SwishX is helping the pharma companies to further grow in other countries as well by combining AI with local market data of different countries. For the tender teams at the pharma and medical device companies, it autonomously evaluates thousands of tenders globally, surfaces most high-probability win opportunities for that company, analyses complex 500+ pages documents, maps relevant products, recommends likely winning pricing and drafts bid documents within minutes.

Dushyant Sapre, Founder and Chief Executive Officer (CEO), SwishX, said, “India’s pharma sector, recognised as the ‘pharmacy of the world,’ drives revenues of over USD 65 billion and emerging markets combined drive USD 400 billion while distributing into over 200 countries. Manufacturing and R&D have become genuinely world-class, but how these companies sell, market, and distribute, is still stuck in the past. Companies often struggle to know where losses are happening, what is selling, which tenders matter most, or how effectively teams are executing in the market. AI agents change that completely. The next big transformation in this industry is not going to happen in the lab. It is going to happen in how these companies go to market. For the first time, companies can move to real-time autonomous execution.”